Published in


Triall partners with Faculty Capital

Triall has partnered with Faculty Capital as part of its pre-sale campaign. Faculty Capital is the venture capital arm of Faculty Group, a collective of synergistic blockchain-native firms that provide a range of solutions to digital asset companies. Their mission is to partner with truly innovative blockchain projects to make their ideas a reality.

Did you know that the $TRL token pre-sale is currently in full swing? Register your interest at to get access to our token sale platform and join our #blockchainforhealth initiative today!

Faculty Capital is a value-driven venture capital firm focused on innovative blockchain projects. They effectively mix deep industry expertise with the combined resources of the Faculty Group and an extensive strategic network to deliver value far beyond money to the projects they support.

The Faculty Capital Innovation Fund (FCIF) is a multi-million dollar fund that invests in early stage blockchain companies with innovative, high growth or disruptive technologies that have the potential to shake up established markets.

“We’re very glad to have Faculty Capital and Faculty Group on board of our initiative. Their multi-disciplinary expertise and extensive network within crypto are of great value to the further buildout of our ecosystem and the success of our native utility token $TRL”- Raymond van der Waal, co-founder at Triall

About Faculty Capital
Faculty Capital invests in thought leaders solving significant problems by utilizing blockchain technology in innovative ways. They support their investments with a hands-on and engaged approach. Faculty Capital’s ethos is to help their portfolio projects to save money, save time, and make the best use of their funds to launch successfully and scale effectively.

Faculty Capital website:
Faculty Group website:

About Triall
Triall is laying the groundwork for tomorrow’s digital playing field in clinical trials. They bring Web 3.0 to medical research by developing a digital ecosystem of blockchain-integrated software solutions. Triall’s blockchain infrastructure makes medical data tamper-resistant and enables secure and efficient connections between the many isolated systems and parties involved in clinical research.

Triall’s mission is to accelerate the introduction of safe and affordable vaccines and therapeutics into society by streamlining clinical trial operations.

Visit the website:



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store